Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Dearen Danny L. | President & CFO | Apr 21 | Option Exercise | 14.19 | 13,208 | 187,422 | 37,201 | Apr 25 08:06 PM | Dearen Danny L. | President & CFO | Apr 21 | Sale | 60.21 | 20,000 | 1,204,137 | 17,201 | Apr 25 08:06 PM | Dearen Danny L. | President & CFO | Apr 20 | Option Exercise | 14.19 | 2,001 | 28,394 | 25,994 | Apr 24 08:35 PM | Dearen Danny L. | President & CFO | Apr 20 | Sale | 60.01 | 2,001 | 120,073 | 23,993 | Apr 24 08:35 PM | Dearen Danny L. | President & CFO | Mar 31 | Option Exercise | 16.00 | 15,000 | 240,031 | 38,993 | Apr 04 08:24 PM | Dearen Danny L. | President & CFO | Mar 31 | Sale | 55.27 | 15,000 | 829,103 | 23,993 | Apr 04 08:24 PM | Sama Rinda | Chief Operating Officer | Feb 21 | Sale | 56.27 | 19,929 | 1,121,415 | 55,854 | Feb 23 08:19 PM | Sama Rinda | Chief Operating Officer | Feb 21 | Sale | 56.53 | 3,392 | 191,750 | 608 | Feb 23 08:19 PM | COHEN RAYMOND W | Chief Executive Officer | Feb 01 | Sale | 60.93 | 8,117 | 494,578 | 160,596 | Feb 02 08:06 PM | Sama Rinda | Chief Operating Officer | Feb 01 | Sale | 60.93 | 5,075 | 309,225 | 75,783 | Feb 02 08:07 PM | Woock John | EVP, Chief Mktg/Strtgy Officer | Feb 01 | Sale | 60.93 | 3,979 | 242,445 | 65,302 | Feb 02 08:06 PM | Ford Alfred J Jr | Chief Commercial Officer | Feb 01 | Sale | 60.93 | 3,705 | 225,750 | 50,834 | Feb 02 08:07 PM | Dearen Danny L. | President & CFO | Feb 01 | Sale | 60.93 | 3,246 | 197,782 | 23,993 | Feb 02 08:06 PM | Noblett Karen | Chief Medical Officer | Feb 01 | Sale | 60.93 | 931 | 56,727 | 42,215 | Feb 02 08:06 PM | Dearen Danny L. | President & CFO | Jan 31 | Option Exercise | 0.00 | 25,250 | 0 | 37,750 | Feb 02 08:06 PM | Ford Alfred J Jr | Chief Commercial Officer | Jan 31 | Option Exercise | 0.00 | 16,500 | 0 | 60,773 | Feb 02 08:07 PM | Sama Rinda | Chief Operating Officer | Jan 31 | Option Exercise | 0.00 | 30,875 | 0 | 94,283 | Feb 02 08:07 PM | Woock John | EVP, Chief Mktg/Strtgy Officer | Jan 31 | Option Exercise | 0.00 | 22,125 | 0 | 76,851 | Feb 02 08:06 PM | Noblett Karen | Chief Medical Officer | Jan 31 | Option Exercise | 0.00 | 10,250 | 0 | 46,849 | Feb 02 08:06 PM | COHEN RAYMOND W | Chief Executive Officer | Jan 31 | Option Exercise | 0.00 | 61,968 | 0 | 191,617 | Feb 02 08:06 PM | COHEN RAYMOND W | Chief Executive Officer | Jan 31 | Sale | 61.15 | 22,904 | 1,400,595 | 168,713 | Feb 02 08:06 PM | Sama Rinda | Chief Operating Officer | Jan 31 | Sale | 61.15 | 13,425 | 820,932 | 80,858 | Feb 02 08:07 PM | Dearen Danny L. | President & CFO | Jan 31 | Sale | 61.16 | 10,511 | 642,822 | 27,239 | Feb 02 08:06 PM | Woock John | EVP, Chief Mktg/Strtgy Officer | Jan 31 | Sale | 61.14 | 7,570 | 462,854 | 69,281 | Feb 02 08:06 PM | Ford Alfred J Jr | Chief Commercial Officer | Jan 31 | Sale | 61.15 | 6,234 | 381,235 | 54,539 | Feb 02 08:07 PM | Noblett Karen | Chief Medical Officer | Jan 31 | Sale | 61.15 | 3,703 | 226,437 | 43,146 | Feb 02 08:06 PM | Woock John | EVP, Chief Mktg/Strtgy Officer | Jan 17 | Option Exercise | 17.48 | 30,215 | 528,050 | 60,976 | Jan 19 08:07 PM | Woock John | EVP, Chief Mktg/Strtgy Officer | Jan 17 | Sale | 67.34 | 30,215 | 2,034,531 | 45,976 | Jan 19 08:07 PM | Ford Alfred J Jr | Chief Commercial Officer | Jan 13 | Option Exercise | 13.52 | 36,015 | 486,817 | 72,788 | Jan 18 08:03 PM | COHEN RAYMOND W | Chief Executive Officer | Jan 13 | Sale | 65.94 | 40,736 | 2,686,001 | 108,899 | Jan 18 08:04 PM | Ford Alfred J Jr | Chief Commercial Officer | Jan 13 | Sale | 66.40 | 36,015 | 2,391,415 | 36,773 | Jan 18 08:03 PM | Lopez Esteban | Director | Dec 13 | Sale | 67.42 | 2,000 | 134,840 | 3,600 | Dec 15 08:12 PM | Dearen Danny L. | See Remarks | Sep 13 | Sale | 75.60 | 656 | 49,594 | 7,500 | Sep 15 08:03 PM | Noblett Karen | Chief Medical Officer | Sep 12 | Option Exercise | 19.19 | 32,483 | 623,335 | 64,082 | Sep 20 08:23 PM | Noblett Karen | Chief Medical Officer | Sep 12 | Sale | 78.16 | 32,483 | 2,538,800 | 31,599 | Sep 20 08:23 PM | Woock John | Chief Marketing Officer | Sep 08 | Option Exercise | 1.52 | 7,500 | 11,427 | 49,776 | Sep 12 08:03 PM | Woock John | Chief Marketing Officer | Sep 08 | Sale | 75.00 | 7,500 | 562,524 | 45,976 | Sep 12 08:03 PM | Noblett Karen | Chief Medical Officer | Sep 07 | Sale | 71.53 | 10,454 | 747,794 | 31,599 | Sep 09 08:06 PM | Woock John | Chief Marketing Officer | Aug 25 | Sale | 72.95 | 7,500 | 547,113 | 45,976 | Aug 26 07:25 PM | Dearen Danny L. | See Remarks | Aug 11 | Option Exercise | 7.99 | 37,502 | 299,691 | 58,156 | Aug 15 08:34 PM | Dearen Danny L. | See Remarks | Aug 11 | Sale | 70.89 | 50,000 | 3,544,523 | 8,156 | Aug 15 08:34 PM | Sama Rinda | Chief Operating Officer | Aug 10 | Option Exercise | 17.04 | 33,850 | 576,872 | 88,508 | Aug 12 07:48 PM | Woock John | Chief Marketing Officer | Aug 10 | Option Exercise | 1.63 | 7,500 | 12,225 | 68,476 | Aug 12 07:49 PM | Sama Rinda | Chief Operating Officer | Aug 10 | Sale | 69.56 | 33,850 | 2,354,650 | 54,658 | Aug 12 07:48 PM | Woock John | Chief Marketing Officer | Aug 10 | Sale | 69.71 | 15,000 | 1,045,647 | 53,476 | Aug 12 07:49 PM | COHEN RAYMOND W | Chief Executive Officer | Aug 08 | Sale | 70.44 | 44,000 | 3,099,326 | 149,635 | Aug 10 07:29 PM | Kiernan Jane E | Director | Jul 05 | Sale | 60.00 | 5,250 | 315,000 | 14,761 | Jul 07 08:20 PM |
|